Many articles have demonstrated that elevations in tumour markers (TMs, e.g., carcinoembryonic antigen [CEA] or cancer antigen 19-9 [CA19-9]) have been associated with poor prognosis in CRC14–18. Here, CEACAM5 is linked to neoplasm.